Background: Early detection of sepsis is crucial for improving patient outcomes. Conventional biomarkers, such as Procalcitonin (PCT) and C Reactive protein(CRP), are frequently employed but have drawbacks, especially when it comes to early sepsis identification. Through the detection of morphological alterations in monocytes during inflammation, Monocyte Distribution Width(MDW), a novel haematological parameter, has become a promising early sepsis indicator compared with CRP and PCT. With this background, we aimed to evaluate the efficacy of MDW as an early indicator of sepsis and to compare its diagnostic accuracy with established biomarkers such as CRP and PCT. Methodology: We conducted a prospective observational study on patients suspected of sepsis with the age ranged from 1 to 90 years. MDW, CRP, and PCT levels were measured. Continuous variables are expressed in Mean & Standard deviation (SD) and the area under the curves (AUCs) obtained from receiver operating characteristic curves were used to evaluate and compare MDW with CRP and PCT. Results: Our study revealed that MDW is increased among sepsis patients along with biomarkers like CRP and PCT. The AUC for MDW comparable with PCT and CRP are 0.917 and 0.864 respectively. We found statistical significance for MDW with both PCT (0.001) and CRP (0.001). Conclusion: MDW outperforms conventional biomarkers like CRP and PCT as an early and accurate indication of sepsis, especially in the early stages of the illness. By adding MDW to routine blood tests, a quick, easy, and affordable way to increase early detection, which is essential for prompt intervention and better patient outcomes is provided.